Simultaneous determination of a new phosphodiesterase-5 inhibitor DA-8159 and its active metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometry |
| |
Authors: | J Kim S J Kim H Y Ji J K Jin S S Lee D S Kim M Yoo W B Kim H S Lee |
| |
Institution: | (1) Faculty of Pharmaceutical Sciences, University of British Columbia, V6T1Z3 Vancouver, Canada;(2) Drug Metabolism and Bioanalysis laboratory, College of Pharmacy, Wonkwang University, 570-749 Iksan, Korea;(3) Research Laboratories, Dong-A Pharm. Co, Ltd, 47-5 Sanggal-Ri, Kiheung-Up, Yongin-Si, 449-900 Kyunggi-Do, Korea |
| |
Abstract: | Summary An LC-MS-MS method for the simultaneous determination of DA-8159 and its active metabolite, DA-8164 in human plasma was developed.
DA-8159, DA-8164 and the internal standard, sildenafil were extracted from human plasma with dichloromethane at basic pH.
A reversephase HPLC separation was performed on Luna phenylhexyl column with the mixture of acetonitrile-ammonium formate
(10 mM, pH 6.0) (60:40,v/v) as mobile phase. The detection of analytes was performed using an electrospray ionization tandem mass spectrometry in the
multiple reaction monitoring mode. The method showed a satisfactory sensitivity (lower limits of quantification, 2.0 ng mL1), precision, accuracy, recovery and selectivity. The successful determination of DA-8159 and DA-8164 in the plasma of a volunteer
who ingested a single dose of 100 mg DA-8159 confirms that the present method can be used for plasma analysis for clinical
trial. |
| |
Keywords: | Column liquid chromatography Tandem mass spectrometry Plasma DA-8159 and metabolite |
本文献已被 SpringerLink 等数据库收录! |
|